[(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action

Sheung-Tsam Kam, W. L. Matier, Cynthia Barcelon-Yang, Robert J. Borgman, John P. O’Donnell, Herman F. Stampfli, Check Y. Sum, W. Gary Anderson

Journal of Medicinal Chemistry · 1984 · 31 citations · 0 references

Concepts

Abstract

Novel [(arylcarbonyl)oxy]propanolamines were synthesized and investigated as potential ultrashort-acting beta-adrenergic receptor blockers. Many of these analogues exhibited good potency and short duration. The N-ureidoalkyl analogue 85 (ACC-9089) has a potency equal to propranolol and a duration of action of about 21 min in the dog. It has been selected as a candidate for further clinical study. Structure-activity relationships and structure-duration relationships for these new beta-blockers are also discussed.